Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity
Abstract COVID-19 patients show varying severity of the disease ranging from asymptomatic to requiring intensive care. Although a number of SARS-CoV-2 specific monoclonal antibodies have been identified, we still lack an understanding of the overall landscape of B-cell receptor (BCR) repertoires in COVID-19 patients. Here, we used high-throughput sequencing of bulk and plasma B-cells collected over multiple time points during infection to characterize signatures of B-cell response to SARS-CoV-2 in 19 patients. Using principled statistical approaches, we determined differential features of BCRs associated with different disease severity. We identified 38 significantly expanded clonal lineages shared among patients as candidates for specific responses to SARS-CoV-2. Using single-cell sequencing, we verified reactivity of BCRs shared among individuals to SARS-CoV-2 epitopes. Moreover, we identified natural emergence of a BCR with cross-reactivity to SARS-CoV-1 and SARS-CoV-2 in a number of patients. Our results provide important insights for development of rational therapies and vaccines against COVID-19..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 02. Nov. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Montague, Zachary [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2020.07.13.20153114 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI018360742 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI018360742 | ||
| 003 | DE-627 | ||
| 005 | 20230429082124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200721s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.07.13.20153114 |2 doi | |
| 035 | |a (DE-627)XBI018360742 | ||
| 035 | |a (biorXiv)10.1101/2020.07.13.20153114 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Montague, Zachary |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract COVID-19 patients show varying severity of the disease ranging from asymptomatic to requiring intensive care. Although a number of SARS-CoV-2 specific monoclonal antibodies have been identified, we still lack an understanding of the overall landscape of B-cell receptor (BCR) repertoires in COVID-19 patients. Here, we used high-throughput sequencing of bulk and plasma B-cells collected over multiple time points during infection to characterize signatures of B-cell response to SARS-CoV-2 in 19 patients. Using principled statistical approaches, we determined differential features of BCRs associated with different disease severity. We identified 38 significantly expanded clonal lineages shared among patients as candidates for specific responses to SARS-CoV-2. Using single-cell sequencing, we verified reactivity of BCRs shared among individuals to SARS-CoV-2 epitopes. Moreover, we identified natural emergence of a BCR with cross-reactivity to SARS-CoV-1 and SARS-CoV-2 in a number of patients. Our results provide important insights for development of rational therapies and vaccines against COVID-19. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Lv, Huibin |e verfasserin |4 aut | |
| 700 | 1 | |a Otwinowski, Jakub |e verfasserin |4 aut | |
| 700 | 1 | |a DeWitt, William S. |e verfasserin |4 aut | |
| 700 | 1 | |a Isacchini, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Yip, Garrick K. |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Wilson W. |e verfasserin |4 aut | |
| 700 | 1 | |a Tsang, Owen Tak-Yin |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Meng |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Hejun |e verfasserin |4 aut | |
| 700 | 1 | |a Wilson, Ian A. |e verfasserin |4 aut | |
| 700 | 1 | |a Peiris, J. S. Malik |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Nicholas C. |e verfasserin |4 aut | |
| 700 | 1 | |a Nourmohammad, Armita |e verfasserin |4 aut | |
| 700 | 1 | |a Mok, Chris Ka Pun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 02. Nov. |
| 773 | 1 | 8 | |g year:2022 |g day:02 |g month:11 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.celrep.2021.109173 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.07.13.20153114 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 02 |c 11 | ||